chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Skull fracture, Subarachnoid haemorrhage
Clinical narrative: Admitting Physician: MD Discharge Attending Physician: Dr.  Primary Care Physician at Discharge: MD  Admission Date: 9/29/2022 Discharge Date: 9/30/2022   HOSPITAL COURSE: Patient is  a 20 y.o. female who presented on 9/29 as a level 2 trauma activation after being struck by a vehicle going approximately 40 mph.  She sustained multifocal SAH, R frontal bone fracture, R sacral alar fracture, and large R forehead hematoma.  She was admitted to trauma.  Neurosurg was consulted; repeat head CT was stable and neuro checks were stable.  She was started on a clear liquid-- >general diet which she tolerated.  Her tertiary exam revealed no additional injuries.  For her R sacral ala fracture, ortho was contacted.  No formal consult was placed as this was a very small fracture and she ambulated without issues.  Plastics was consulted for her frontal sinus fx and abrasion; this was managed with elevated HOB, ice, and baci to the abrasion TID.  Neuropsych was consulted and did not require outpatient therapy.  PT/OT was consulted but she was ambulating without assistance and was okay for discharge home.  By discharge, her pain was stable with PO pain meds, she was tolerating a diet, she was ambulating as above, and she was urinating spontaneously without any issues.  The patient was discharged to home on 9/30 in stable condition.  Prior to discharge, discharge instructions were discussed with the patient and all questions were answered.  PRESENTING PROBLEM and ADMISSION DIAGNOSIS Subarachnoid hemorrhage [I60.9] Abrasion of scalp, initial encounter [S00.01XA] Closed fracture of frontal bone, initial encounter [S02.0XXA] Closed fracture of sacrum, unspecified portion of sacrum, initial encounter [S32.10XA] COVID-19 [U07.1] Subarachnoid hemorrhage
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Received dose, no adverse or untoward symptoms.
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient underage of 65yrs, no symptoms reported
Age: 74.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Aortic valve incompetence, Brain natriuretic peptide increased, COVID-19, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Discharge Provider: Primary Care Provider:  Admission Date: 9/29/2022 Discharge Date: Oct 1, 2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic combined systolic and diastolic CHF (congestive heart failure) (HCC) [I50.43] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 75 year old female with PMHx of chronic systolic CHF, HTN, CKD3, CAD, A-fib who presented to the hospital with shortness of breath and cough. She was found to be COVID-19 positive in the ER and had hypoxia. Patient had a CXR showing bilateral infiltrates. However the patient also had a significantly elevated BNP and was given IV lasix along with remdesivir and decadron. Patient improved quickly and was able to be weaned to room air off her O2. Patient diuresed well. She was afebrile after admission. Given her quick improvement  (and symptoms only a few days) decadron was stopped as COVID-19 pneumonia was unlikely. Patient was kept and given 3 days of IV remdesivir. Patient was feeling much better at the time of discharge, she was breathing well on room air with no shortness of breath or cough, no fever. Patient was then considered stable for discharge home. Patient was instructed on signs and symptoms of when to return to the ER.
Age: 74.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Chest X-ray abnormal, Condition aggravated, Cough, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Discharge Provider: Primary Care Provider:  Admission Date: 9/29/2022 Discharge Date: Oct 1, 2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic combined systolic and diastolic CHF (congestive heart failure) (HCC) [I50.43] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 75 year old female with PMHx of chronic systolic CHF, HTN, CKD3, CAD, A-fib who presented to the hospital with shortness of breath and cough. She was found to be COVID-19 positive in the ER and had hypoxia. Patient had a CXR showing bilateral infiltrates. However the patient also had a significantly elevated BNP and was given IV lasix along with remdesivir and decadron. Patient improved quickly and was able to be weaned to room air off her O2. Patient diuresed well. She was afebrile after admission. Given her quick improvement  (and symptoms only a few days) decadron was stopped as COVID-19 pneumonia was unlikely. Patient was kept and given 3 days of IV remdesivir. Patient was feeling much better at the time of discharge, she was breathing well on room air with no shortness of breath or cough, no fever. Patient was then considered stable for discharge home. Patient was instructed on signs and symptoms of when to return to the ER.
Age: 74.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Hypoxia, Left ventricular failure, Lung infiltration, Mitral valve incompetence, Polyuria
Clinical narrative: Discharge Provider: Primary Care Provider:  Admission Date: 9/29/2022 Discharge Date: Oct 1, 2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic combined systolic and diastolic CHF (congestive heart failure) (HCC) [I50.43] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 75 year old female with PMHx of chronic systolic CHF, HTN, CKD3, CAD, A-fib who presented to the hospital with shortness of breath and cough. She was found to be COVID-19 positive in the ER and had hypoxia. Patient had a CXR showing bilateral infiltrates. However the patient also had a significantly elevated BNP and was given IV lasix along with remdesivir and decadron. Patient improved quickly and was able to be weaned to room air off her O2. Patient diuresed well. She was afebrile after admission. Given her quick improvement  (and symptoms only a few days) decadron was stopped as COVID-19 pneumonia was unlikely. Patient was kept and given 3 days of IV remdesivir. Patient was feeling much better at the time of discharge, she was breathing well on room air with no shortness of breath or cough, no fever. Patient was then considered stable for discharge home. Patient was instructed on signs and symptoms of when to return to the ER.
Age: 74.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Discharge Provider: Primary Care Provider:  Admission Date: 9/29/2022 Discharge Date: Oct 1, 2022  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic combined systolic and diastolic CHF (congestive heart failure) (HCC) [I50.43] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 75 year old female with PMHx of chronic systolic CHF, HTN, CKD3, CAD, A-fib who presented to the hospital with shortness of breath and cough. She was found to be COVID-19 positive in the ER and had hypoxia. Patient had a CXR showing bilateral infiltrates. However the patient also had a significantly elevated BNP and was given IV lasix along with remdesivir and decadron. Patient improved quickly and was able to be weaned to room air off her O2. Patient diuresed well. She was afebrile after admission. Given her quick improvement  (and symptoms only a few days) decadron was stopped as COVID-19 pneumonia was unlikely. Patient was kept and given 3 days of IV remdesivir. Patient was feeling much better at the time of discharge, she was breathing well on room air with no shortness of breath or cough, no fever. Patient was then considered stable for discharge home. Patient was instructed on signs and symptoms of when to return to the ER.
Age: 14.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The patient is 14 and received the Moderna Bivalent vaccine only authorized for those 18 and older.
Age: 43.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the Department of Health it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Pain in extremity, Sleep disorder
Clinical narrative: Received flu vaccine on 10/4/2022, arm was sore after vaccine but now has pain running down arm to inner elbow that keeps her up at night.
Age: 33.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the clinic it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was underage of 65yrs, no symptoms reported
Age: 26.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Exercise tolerance decreased, Impaired driving ability, Joint range of motion decreased, Loss of personal independence in daily activities
Clinical narrative: Within the hour after receiving the flu shot in my left arm, my shoulder became painful with active movement. Specifically, abduction of the left shoulder caused severe pain even with passive movement. This pain was significant for several days to the point that I was unable to use my left arm to do anything. Opening the car door, driving, getting into bed, putting on clothing was painful. Symptoms improved gradually so that I am able to use my arm, but I am not able to work out yet. Range of motion is still limited by pain 2 weeks after the vaccine. Treatment has included advil, ice, and rest.
Age: 26.0
Sex: M
Vaccine: FLU4
Symptoms: Musculoskeletal disorder, Pain
Clinical narrative: Within the hour after receiving the flu shot in my left arm, my shoulder became painful with active movement. Specifically, abduction of the left shoulder caused severe pain even with passive movement. This pain was significant for several days to the point that I was unable to use my left arm to do anything. Opening the car door, driving, getting into bed, putting on clothing was painful. Symptoms improved gradually so that I am able to use my arm, but I am not able to work out yet. Range of motion is still limited by pain 2 weeks after the vaccine. Treatment has included advil, ice, and rest.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache, Iritis, Ocular hyperaemia, Photophobia
Clinical narrative: Five days after receiving the vaccine I noticed my eyes became blood red and very light sensitive. I had a headache above my eyes the lower half of my eyes were really blood shot. I made an appointment with my eye doctor to go in and fine out what was going on. I went in to see my eye doctor who diagnosed me with acute iritis to my right eye, he prescribed me a Prednisone Eye drop 1%. I have been using them for two weeks and am slowly being dosed down so that I can stop using them.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Cough, Exercise tolerance decreased, Fatigue
Clinical narrative: I was extremely tired. I had a low-grade fever. Strangely my thighs and my hips ached; lasting 2-3 days. I had some nasal congestion WITHOUT a cough. I sort of had a come and go headache. The feeling of exhaustion lasted about 2-3 weeks. I noticed since testing positive; I can't tolerate exercise as well as I did before. I excessively sweat now and get tired a lot easier. Surprising my asthma did not trigger while being positive.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Nasal congestion, Pain in extremity, Pyrexia
Clinical narrative: I was extremely tired. I had a low-grade fever. Strangely my thighs and my hips ached; lasting 2-3 days. I had some nasal congestion WITHOUT a cough. I sort of had a come and go headache. The feeling of exhaustion lasted about 2-3 weeks. I noticed since testing positive; I can't tolerate exercise as well as I did before. I excessively sweat now and get tired a lot easier. Surprising my asthma did not trigger while being positive.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I was extremely tired. I had a low-grade fever. Strangely my thighs and my hips ached; lasting 2-3 days. I had some nasal congestion WITHOUT a cough. I sort of had a come and go headache. The feeling of exhaustion lasted about 2-3 weeks. I noticed since testing positive; I can't tolerate exercise as well as I did before. I excessively sweat now and get tired a lot easier. Surprising my asthma did not trigger while being positive.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Nasal congestion, Pain, Rash
Clinical narrative: In the evening I started to feel really tired and had some nasal congestion. I took a COVID-19 test that was negative. 2 days later I went to urgent care and was given a z-pack medication. A few days later I took a COVID-19 test that came back positive. By that time my symptoms had gotten worse I was severely congested, had body aches, and was very tired. I went to see my doctor, and my oxygen level was at 94.  I was prescribed Paxlovid. I had to stop taking it because I broke out in a rash. I am still having the same symptoms.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: In the evening I started to feel really tired and had some nasal congestion. I took a COVID-19 test that was negative. 2 days later I went to urgent care and was given a z-pack medication. A few days later I took a COVID-19 test that came back positive. By that time my symptoms had gotten worse I was severely congested, had body aches, and was very tired. I went to see my doctor, and my oxygen level was at 94.  I was prescribed Paxlovid. I had to stop taking it because I broke out in a rash. I am still having the same symptoms.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: received 0.25 dose, no adverse or untoward events
Age: 76.0
Sex: M
Vaccine: FLU4
Symptoms: Bedridden, Fatigue, Headache, Pain
Clinical narrative: Severe fatigue, body aches, headache. Required bed rest for 24 hours
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient underage of 65yrs, no reported symptoms
Age: 11.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injected limb mobility decreased, Injection site discomfort, Injection site muscle weakness, Injection site pain
Clinical narrative: Two shots to left arm. 5 hours in: arm became very tight, very sore and weak. Lasted for just over 2 days.  Hard to lift use arm.
Age: 29.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: RPh on-duty on 09/30/2022 administered a BiValent booster to the patient, but it was only the 2nd dose in the series for the patient. Per current guidelines, they should've gotten 2nd dose in the initial series rather the BiValent Booster .
Age: 0.5
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation error
Clinical narrative: On 10/07/2022, I accidentally used 1.3 mL of normal saline diluent for the Pfizer-BioNTech COVID vaccine for ages 6 months-<5 years of age. Instructions for this vaccine are very clear that one is supposed to use 2.2 mL of normal saline to dilute the 6 month-<5 years vaccine, but I mistakenly used the The 1.3 mL of diluent used for the ages 5-11 vaccine vials. This under-diluted form of the vaccine was administered to this patient. This means that this patient received a 4.7 mcg/0.2 mL dose of the vaccine instead of the advised 3 mcg/0.2 mL. I have already notified both my office manager and the MD in the office at the time I realized my mistake, and I have reported this incident to both Pfizer and the CDC.  NO ADVERSE REACTION(S) THAT WRITER IS AWARE OF AT THIS TIME (10/10/2022).
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain
Clinical narrative: sore throat, cough
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Alanine aminotransferase increased, Anticoagulant therapy, Aspartate aminotransferase increased, Blood creatinine increased
Clinical narrative: Discharge Provider: DO Primary Care Provider : MD    Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems:   Goals of care, counseling/discussion   Multiple comorbid conditions   PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive.  Patient was also noticed to have some degree of ST changes involving the inferior leads.  Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab.  He received IV fluids along with antibiotics.  Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization.  TTE was performed and showed LVEF of 60-65% with normal RV function and size.  No pericardial effusion.  Given his persistent hypotension, patient was started on norepinephrine infusion.  MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock.  CT head was unremarkable.   Patient's shock it did improve and he was weaned off pressor therapy.  Patient renal failure also did improve.  Patient was continued to seen by Cardiology recommendation was to continue with medical therapy.  Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement.  Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days.  On discharge patient will be continued on aspirin daily.  Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services.  Patient was discharged under hospice care on 10/07/2022
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid increased, Blood potassium increased, COVID-19, Computerised tomogram head normal, Echocardiogram normal
Clinical narrative: Discharge Provider: DO Primary Care Provider : MD    Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems:   Goals of care, counseling/discussion   Multiple comorbid conditions   PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive.  Patient was also noticed to have some degree of ST changes involving the inferior leads.  Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab.  He received IV fluids along with antibiotics.  Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization.  TTE was performed and showed LVEF of 60-65% with normal RV function and size.  No pericardial effusion.  Given his persistent hypotension, patient was started on norepinephrine infusion.  MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock.  CT head was unremarkable.   Patient's shock it did improve and he was weaned off pressor therapy.  Patient renal failure also did improve.  Patient was continued to seen by Cardiology recommendation was to continue with medical therapy.  Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement.  Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days.  On discharge patient will be continued on aspirin daily.  Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services.  Patient was discharged under hospice care on 10/07/2022
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction normal, Electrocardiogram ST-T change, Epistaxis, Hyperkalaemia, Hypertension
Clinical narrative: Discharge Provider: DO Primary Care Provider : MD    Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems:   Goals of care, counseling/discussion   Multiple comorbid conditions   PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive.  Patient was also noticed to have some degree of ST changes involving the inferior leads.  Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab.  He received IV fluids along with antibiotics.  Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization.  TTE was performed and showed LVEF of 60-65% with normal RV function and size.  No pericardial effusion.  Given his persistent hypotension, patient was started on norepinephrine infusion.  MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock.  CT head was unremarkable.   Patient's shock it did improve and he was weaned off pressor therapy.  Patient renal failure also did improve.  Patient was continued to seen by Cardiology recommendation was to continue with medical therapy.  Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement.  Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days.  On discharge patient will be continued on aspirin daily.  Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services.  Patient was discharged under hospice care on 10/07/2022
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertransaminasaemia, Hypotension, Intensive care, Mental status changes, Nasal cavity packing
Clinical narrative: Discharge Provider: DO Primary Care Provider : MD    Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems:   Goals of care, counseling/discussion   Multiple comorbid conditions   PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive.  Patient was also noticed to have some degree of ST changes involving the inferior leads.  Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab.  He received IV fluids along with antibiotics.  Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization.  TTE was performed and showed LVEF of 60-65% with normal RV function and size.  No pericardial effusion.  Given his persistent hypotension, patient was started on norepinephrine infusion.  MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock.  CT head was unremarkable.   Patient's shock it did improve and he was weaned off pressor therapy.  Patient renal failure also did improve.  Patient was continued to seen by Cardiology recommendation was to continue with medical therapy.  Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement.  Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days.  On discharge patient will be continued on aspirin daily.  Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services.  Patient was discharged under hospice care on 10/07/2022
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Renal failure, SARS-CoV-2 test positive, Septic shock, Troponin increased
Clinical narrative: Discharge Provider: DO Primary Care Provider : MD    Admission Date: 9/26/2022 Discharge Date: 10/07/2022 Admitting Diagnoses: Active Problems:   Goals of care, counseling/discussion   Multiple comorbid conditions   PRESENTING PROBLEM: Septic shock    HOSPITAL COURSE: 87 y.o. man who has a past medical history significant for hypothyroidism, prostate cancer, hypertension, depression, and GERD who was brought to the emergency department with altered mental status and was found to be hypotensive.  Patient was also noticed to have some degree of ST changes involving the inferior leads.  Initial workup was significant for elevated lactic acid at 4.6, hyperkalemia with K of 6.2, AKI with creatinine of 2.73, mild transaminitis with AST of 144, ALT of 95, initial elevated troponin but with flat delta, and positive COVID swab.  He received IV fluids along with antibiotics.  Cardiology evaluated the patient and given his AKI, decision was made not to proceed with a left heart catheterization.  TTE was performed and showed LVEF of 60-65% with normal RV function and size.  No pericardial effusion.  Given his persistent hypotension, patient was started on norepinephrine infusion.  MICU team was consulted for hypertension and decision was made to transfer the patient to MICU service for evaluation and management of shock.  CT head was unremarkable.   Patient's shock it did improve and he was weaned off pressor therapy.  Patient renal failure also did improve.  Patient was continued to seen by Cardiology recommendation was to continue with medical therapy.  Patient was started on aspirin and Eliquis however unfortunately patient developed a persistent nosebleed which required ENT evaluation and rhino rocket placement.  Recommendation from ENT is to use hold the Eliquis and aspirin for a total of 5 days.  On discharge patient will be continued on aspirin daily.  Will continue to hold Eliquis due to his risk of bleeding and limited benefit on hospice services.  Patient was discharged under hospice care on 10/07/2022
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Symptoms included runny nose and cough. Took course of Paxlovid and symptoms cleared. Symptoms returned 9 days after initial occurrence with a positive home test, abated 6 days later.
Age: 28.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the Department of Health it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: The patient received the Pfizer Bivalent booster that is authorized for those 12 and older, and the patient is 10.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: 9/19/2022 I went to the doctor after being in the hospital, not related to vaccine, for a checkup. Because my wife had tested positive for COVID, I took a test and it came back positive.  I remained asymptomatic.
Age: 74.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Arthralgia, Bell's palsy, Eye pain, Immunisation reaction, Neck pain
Clinical narrative: PATIENT WAS VACCINATED ON TUESDAY 10/04/22 AT OUR PHARMACY WITH COVID BIVALENT VACCINE AND THE FLUZONE HD VACCINE. HE CONTACTED ME ON SATURDAY 10/08/2022 STATING HE HAD A EACTION TO THE VACCINES GIVEN HIM AND THE REACTION OCCURED LATER IN THE EVENING ON THE SAME DAY HE RECEIVED THE VACCINES. HE STATED HIS PCP DR AND HIS DENTIST STATED HE HAD BELL PALSY AS A RESULT OF THE VACCINES. HE STATED HE WAS EXPERIENCING PAIN IN HIS EYE, NECK AND SHOULDER.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: I had a sore arm after receiving the vaccine which lasted two days.  I started to feel symptoms of sore throat, swollen lymph nodes, exhaustion, chills and fever of 102 degrees on 07/26/ 2022.  I went to a drive through testing spot, and I tested positive for COVID-19.  I contacted my primary care doctor and was given the prescription Paxlovid but I did not take it due to medication that I take.  I took Tylenol to help with the symptoms.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I had a sore arm after receiving the vaccine which lasted two days.  I started to feel symptoms of sore throat, swollen lymph nodes, exhaustion, chills and fever of 102 degrees on 07/26/ 2022.  I went to a drive through testing spot, and I tested positive for COVID-19.  I contacted my primary care doctor and was given the prescription Paxlovid but I did not take it due to medication that I take.  I took Tylenol to help with the symptoms.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: received 0.25, no untoward or adverse events.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Hypertension
Clinical narrative: dizziness, high blood pressure,
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient Covid +ve 7/5/22. Expired 9/30/22.
Age: 59.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient underage of 65yrs, no reported symptoms
Age: 60.0
Sex: M
Vaccine: FLU4
Symptoms: Chills, Feeling cold
Clinical narrative: Shivering/persistent cold feeling
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Cough, Fatigue
Clinical narrative: Admission Date: 10/1/2022 Discharge Date: 10/03/2022 Admitting Diagnoses: Principal Problem:   COVID  PRESENTING PROBLEM: COVID   HOSPITAL COURSE: The patient is a 80 y.o. male with past medical history significant for hyperlipidemia, coronary artery disease, OSA, type 2 diabetes, sick sinus syndrome, pacemaker, ischemic cardiomyopathy, heart failure that presented to  emergency department for generalized weakness and fatigue. Found to be positive for COVID-19. Not hypoxic. Dry cough. Chest x-ray fshowed decreased lung volume, no evidence pleural effusions or pneumonia Fatigue and cough improved with supportive care and remdesivir. PT evaluated and recommended discharge home as he is progressing to baseline no continued PT needs identified. Patient cough improved with supportive cares and 3 doses of remdesivir. Patient discharged home on 10/3.     Close follow up advised as noted below including following up with primary care provider doctor. Patient  expressed understanding and agreement with this plan. Patient  in agreement with and requested discharge on 10/03/2022
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Lung disorder, SARS-CoV-2 test positive
Clinical narrative: Admission Date: 10/1/2022 Discharge Date: 10/03/2022 Admitting Diagnoses: Principal Problem:   COVID  PRESENTING PROBLEM: COVID   HOSPITAL COURSE: The patient is a 80 y.o. male with past medical history significant for hyperlipidemia, coronary artery disease, OSA, type 2 diabetes, sick sinus syndrome, pacemaker, ischemic cardiomyopathy, heart failure that presented to  emergency department for generalized weakness and fatigue. Found to be positive for COVID-19. Not hypoxic. Dry cough. Chest x-ray fshowed decreased lung volume, no evidence pleural effusions or pneumonia Fatigue and cough improved with supportive care and remdesivir. PT evaluated and recommended discharge home as he is progressing to baseline no continued PT needs identified. Patient cough improved with supportive cares and 3 doses of remdesivir. Patient discharged home on 10/3.     Close follow up advised as noted below including following up with primary care provider doctor. Patient  expressed understanding and agreement with this plan. Patient  in agreement with and requested discharge on 10/03/2022
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Late in the day on 8/31/22, the rescinded order for the use of the monovalent Pfizer and Moderna vaccine as boosters for people aged 12 years and older. The information took a little time to trickle from the Government to staff and then to the staff administering vaccine. Because of this delay, some monovalent vaccine throughout was inadvertently given after 8/31/22. They stated that any monovalent vaccine administered as a booster dose after was rescinded would be considered a vaccine error. At a recent Immunization Subcommittee meeting, we discussed this and our medical providers stated that any monovalent vaccine given as a booster dose on 9/1/2022 or after should have VAERS report completed on them per the requirements.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired and given BUD
Age: 14.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Clonus, Dizziness, Loss of consciousness, Syncope
Clinical narrative: on getting 2nd shot she said "i think i'm  going to pass out"  Pt has syncopal event after immunizations today. Patient was seated for immz. She vocalized she felt like she was going to pass out. Mom and I layed her down. She has a mild clonus and was "out" for about 10 seconds. Pt woke spontaneously and was not post ictal. Pt was kept supine for 5 minutes during history portion of appointment and gradually head of table was raised to 90 degrees. Pt was completely recovered in 10 minutes and was advised to tell staff in future she fainted after a shot in past
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Death, Hyperhidrosis, Pallor, Pulse absent
Clinical narrative: Received vaccine at approx. 11am on 10-7-2022  at 9:45pm on 10-7-2022, resident was diaphoretic, B/P 118/84,  HR 125,  PSOX 98%, at 10:10pm, feeling better, at 10:45pm BP 90/50 diaphoretic , weak and pale, 911 was called, 11:29pm 911 arrived, talked to resident he was able to stand to transfer to stretcher and then became weak, dry heaves, and he stopped breathing, resident was a DNR, so breathing was assisted until pulse stopped, pronounced deceased by  911 at 11:45pm
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory arrest, Retching
Clinical narrative: Received vaccine at approx. 11am on 10-7-2022  at 9:45pm on 10-7-2022, resident was diaphoretic, B/P 118/84,  HR 125,  PSOX 98%, at 10:10pm, feeling better, at 10:45pm BP 90/50 diaphoretic , weak and pale, 911 was called, 11:29pm 911 arrived, talked to resident he was able to stand to transfer to stretcher and then became weak, dry heaves, and he stopped breathing, resident was a DNR, so breathing was assisted until pulse stopped, pronounced deceased by  911 at 11:45pm
Age: 55.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the Department of Health it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 58.0
Sex: M
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient underage of 65yrs, no reported reaction
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: hospitalized over a year later
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The Group called me to report that they mistakenly administered an expired COVID-19 vaccine for my five year old. The vaccine expired on August 31st and it was injected on September 7th. I received a call on October 4th regarding this error as their office sought guidance from the CDC and Pfizer.   Administering an expired vaccine was a concern and I contacted the local department of health on where to best report this error.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: received 0.25 dose, no untoward or adverse reactions.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Rash, Rash papular, Rash pruritic, Urticaria
Clinical narrative: rashes after HPV: 1. distinctive and discrete papular rash 15 cm area over deltoid 2. papular/??urticarial rash on face - itchy. No diffuse rash, no SOB or other systemic sx.
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram, Dizziness, Face injury, Fall, Headache
Clinical narrative: That night, I started experiencing intense headaches. The headaches worsened over the night and morning. In the morning, I got dizzy and fell. I completely blacked out and I bashed my face into the night stand. I also cut my nose. I went to the ER and received stitches.
Age: 52.0
Sex: M
Vaccine: COVID19-2
Symptoms: Loss of consciousness, Skin laceration
Clinical narrative: That night, I started experiencing intense headaches. The headaches worsened over the night and morning. In the morning, I got dizzy and fell. I completely blacked out and I bashed my face into the night stand. I also cut my nose. I went to the ER and received stitches.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Injection site bruising, Injection site haemorrhage, Injection site swelling, Muscle twitching
Clinical narrative: given flu vaccine in LD IM, site bleed and started swelling to size of golf ball. by 1130 am no swelling noted, bruise present. PT reported numbness in arm and dull ache, fingers twitching continuing off and on.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Pain
Clinical narrative: given flu vaccine in LD IM, site bleed and started swelling to size of golf ball. by 1130 am no swelling noted, bruise present. PT reported numbness in arm and dull ache, fingers twitching continuing off and on.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Late in the day on 8/31/22, the FDA rescinded the EUA order for the use of the monovalent Pfizer and Moderna vaccine as boosters for people aged 12 years and older. The information took a little time to trickle from the staff and then to the staff administering vaccine. Because of this delay, some monovalent vaccine throughout was inadvertently given after 8/31/22. The CDC stated that any monovalent vaccine administered as a booster dose after the EUA was rescinded would be considered a vaccine error. At a recent meeting, we discussed this and our medical providers stated that any monovalent vaccine given as a booster dose on 9/1/2022 or after should have VAERS report completed on them per the CDC's requirements.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Dizziness, Drain of cerebral subdural space, Haemorrhagic stroke, Headache
Clinical narrative: As soon as I received the Pfizer booster I was immediately sick. I was suffering severe headaches, dizziness etc. I followed up 5 days later with my ENT and expressed what I was feeling. He assured me that it had nothing to do with my sinuses, etc. The headaches did not go away and 7 weeks later I suffered a hemorrhagic stroke. On February 27, 2022 my left side went completely numb and I was rushed to the hospital and put into a CT scan where I heard the techs talking about my serious bleed. That was the last thing I remember until mid April. I was sedated and in an induced coma. A bolt was placed in my head and then a drain to try to relieve the pressure. I have been in extensive rehabilitation since April 1, 2022 but I have not regained any function of my left side and I am in a wheelchair. My wife and children take care of me on a daily basis.  I have had several CT scans and MRI's as well as having been seen by many Neurologists and Neuosurgeons looking for answers. Before Feb 27, I was in great shape. I exercised, ate right and never once ever had High BP until the day I was given the Pfizer booster injection.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Immediate post-injection reaction, Loss of personal independence in daily activities, Magnetic resonance imaging, Malaise
Clinical narrative: As soon as I received the Pfizer booster I was immediately sick. I was suffering severe headaches, dizziness etc. I followed up 5 days later with my ENT and expressed what I was feeling. He assured me that it had nothing to do with my sinuses, etc. The headaches did not go away and 7 weeks later I suffered a hemorrhagic stroke. On February 27, 2022 my left side went completely numb and I was rushed to the hospital and put into a CT scan where I heard the techs talking about my serious bleed. That was the last thing I remember until mid April. I was sedated and in an induced coma. A bolt was placed in my head and then a drain to try to relieve the pressure. I have been in extensive rehabilitation since April 1, 2022 but I have not regained any function of my left side and I am in a wheelchair. My wife and children take care of me on a daily basis.  I have had several CT scans and MRI's as well as having been seen by many Neurologists and Neuosurgeons looking for answers. Before Feb 27, I was in great shape. I exercised, ate right and never once ever had High BP until the day I was given the Pfizer booster injection.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Medical induction of coma, Mobility decreased, Wheelchair user
Clinical narrative: As soon as I received the Pfizer booster I was immediately sick. I was suffering severe headaches, dizziness etc. I followed up 5 days later with my ENT and expressed what I was feeling. He assured me that it had nothing to do with my sinuses, etc. The headaches did not go away and 7 weeks later I suffered a hemorrhagic stroke. On February 27, 2022 my left side went completely numb and I was rushed to the hospital and put into a CT scan where I heard the techs talking about my serious bleed. That was the last thing I remember until mid April. I was sedated and in an induced coma. A bolt was placed in my head and then a drain to try to relieve the pressure. I have been in extensive rehabilitation since April 1, 2022 but I have not regained any function of my left side and I am in a wheelchair. My wife and children take care of me on a daily basis.  I have had several CT scans and MRI's as well as having been seen by many Neurologists and Neuosurgeons looking for answers. Before Feb 27, I was in great shape. I exercised, ate right and never once ever had High BP until the day I was given the Pfizer booster injection.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bell's palsy, Dyskinesia, Eyelid function disorder, Facial paralysis, Facial paresis
Clinical narrative: Patient reported that her symptoms began the morning of October 5th, 2022. The patient noted waking up with her right eye being unable to close, and with a twisting of her mouth that made it difficult for her to drink fluids. She endorsed eye dropping and facial weakness. Patient stated she had similar symptoms when she had Bell's Palsy about 12 years ago. Patient was diagnosed with Bell's Palsy at a clinic visit on October 5th. Prednisone 60 mg daily for 7 days and Acyclovir 800 mg three times a day for 7 days were prescribed for treatment. Patient was also instructed to use eye drops in her right eye, and to place a patch on it at night to assist in maintaining moisture. On a follow up call on October 6th, the patient reported that her symptoms had not yet resolved.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: shot was given a s a booster even though new booster is already on the market
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the Department of Health it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired and given BUD
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: recieved 0.3 dose, no untoward or adverse events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: shot was given as a booster even though booster is already on market
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: shot was given as a booster even though new booster is already on market
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Late in the day on 8/31/22, the rescinded order for the use of the monovalent Pfizer and Moderna vaccine as boosters for people aged 12 years and older. The information took a little time to trickle from the Government to staff and then to the staff administering vaccine. Because of this delay, some monovalent vaccine throughout was inadvertently given after 8/31/22. They stated that any monovalent vaccine administered as a booster dose after was rescinded would be considered a vaccine error. At a recent Immunization Subcommittee meeting, we discussed this and our medical providers stated that any monovalent vaccine given as a booster dose on 9/1/2022 or after should have VAERS report completed on them per the requirements.
Age: 28.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the clinic it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: Dizziness headache intermittent buzzing in ears muscle aches joint pain fatigue
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Tinnitus
Clinical narrative: Dizziness headache intermittent buzzing in ears muscle aches joint pain fatigue
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: received 0.3 dose, no untoward or adverse reactions.
Age: 44.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Product storage error
Clinical narrative: While working with the Department of Health it was determined that our vaccines were out of the temperature recommendations for a brief period of time before vaccination.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: patient came in for moderna bivalent but was given moderna pediatric monovalent. no adverse reaction
Age: 79.0
Sex: M
Vaccine: FLUA4
Symptoms: Arthralgia, Hypoaesthesia, Neck pain, Pain
Clinical narrative: Flu shot administered on Fri 9/30,started feeling sore and achy on Sun 10/2 and the soreness and numbness has spread into my right shoulder and up into my neck,it is currently still sore,numb and achy as of today 10/10/2022. I have gotten a yearly flu shot my entire life but have never felt such lasting pain and numbness.